Altria Launches Next-Gen Nicotine Pouch 'on! PLUS' Nationwide After Securing First FDA Expedited Approval

Altria has officially launched its next-generation oral nicotine pouch, 'on! PLUS', across the United States. This isn't just another product launch; it's a major strategic move backed by a first-of-its-kind regulatory green light from the U.S. Food and Drug Administration (FDA). In December 2025, ‘on! PLUS’ became the very first product to receive marketing authorization through the FDA’s new PMTA ‘expedited review pilot program’. This gives Altria a powerful combination of regulatory certainty and the ability to distribute nationwide, something many competitors lack.This launch was the culmination of a series of carefully planned steps. First, the groundwork was laid in January 2025 when the FDA authorized products from ZYN, the market leader. This set a clear precedent: only FDA-approved pouches could be legally sold. Second, recognizing the need for a faster process, the FDA launched its expedited pilot program in September 2025. Third, Altria’s subsidiary had already submitted its application for ‘on! PLUS’ back in June 2024, positioning it perfectly to be the first beneficiary of this new, faster regulatory path.The U.S. nicotine pouch market is heavily dominated by ZYN, which commands over 60% of the market by volume. Altria’s existing ‘on!’ brand has seen its share decline to around 13%, making the nationwide launch of ‘on! PLUS’ a necessary counterattack. Altria is betting on its differentiated product, which features a unique ‘soft-feel’ mesh material called NICOSILK, to win over consumers from the dominant competitor.This battle isn't just about regulation and product features, though. The market dynamics are also shaped by aggressive promotions from ZYN and emerging tax policies. States like Illinois and Indiana have already started taxing nicotine pouches, which could influence pricing strategies and consumer demand. Altria must navigate these challenges while rapidly scaling its distribution in convenience stores across the country.Ultimately, the success of ‘on! PLUS’ will be a key factor for Altria's valuation. Each percentage point of market share it can capture is worth an estimated $55 to $67 million in annual retail sales. The company's ability to execute this nationwide rollout will be closely watched in the coming months.- PMTA (Premarket Tobacco Product Application): The application that manufacturers must submit to the FDA to demonstrate that a new tobacco product is appropriate for the protection of public health.- NICOSILK: A proprietary mesh material developed by Altria for its 'on! PLUS' pouches, designed to provide a softer and more comfortable user experience.- Off-take: A term used in retail to describe the volume of product sold to consumers from retail shelves over a specific period.